Royalty Pharma plc RPRX
Set alert
66.52 USD -0.66 -0.98%
At close
67.75 +1.23 +1.85%
Pre-market · Nov 3, 8:33 AM ET
66.43 Day range 67.10
36.03 52-week range 67.71
- YTD
- +72.15%
- 1 year
- +78.34%
- Open
- 66.97
- Prev close
- 67.18
- Mkt cap
- 38.44B
- Vol
- 2.87M
- Avg vol
- 3.08M
- EPS
- 1.88
- P/E
- 35.38
- Div yield
- 1.43%
More statistics
- Low
- 66.43
- High
- 67.10
- Forward P/E
- 11.45
- Beta
- 0.36
- Short ratio
- 4.30
- Inst. own
- 90.20%
- Dividend
- 0.94
- Ex-div date
- Nov 12, 2026
- Earnings
- Nov 4, 2026
- 50-d avg
- 60.28
- 200-d avg
- 53.22
- 1y target
- 65.38
1D chart
Signals (92)
| Name | Time | Ago |
|---|---|---|
| RSI: Oversold | 3:58 PM | 16 hours ago |
| SMA: Bearish | 3:43 PM | 16 hours ago |
| MACD: Sell Signal | 3:43 PM | 16 hours ago |
| SMA: Bullish | 3:41 PM | 17 hours ago |
| MACD: Buy Signal | 3:41 PM | 17 hours ago |
| SMA: Bullish | 3:36 PM | 17 hours ago |
| SMA: Bearish | 3:31 PM | 17 hours ago |
| SMA: Bearish | 3:24 PM | 17 hours ago |
| MACD: Sell Signal | 3:14 PM | 17 hours ago |
| MACD: Buy Signal | 3:01 PM | 17 hours ago |
| SMA: Bullish | 2:59 PM | 17 hours ago |
| SMA: Bullish | 2:59 PM | 17 hours ago |
| SMA: Bearish | 2:58 PM | 17 hours ago |
| SMA: Bearish | 2:57 PM | 17 hours ago |
| MACD: Sell Signal | 2:52 PM | 17 hours ago |
| RSI: Overbought | 2:46 PM | 17 hours ago |
| SMA: Bullish | 2:36 PM | 18 hours ago |
| SMA: Bearish | 2:35 PM | 18 hours ago |
| SMA: Bullish | 2:34 PM | 18 hours ago |
| SMA: Bearish | 2:32 PM | 18 hours ago |
Newest 20 of 92.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 65.38 -1.7% downside
Now 66.52
- Target (low)
- 61.00
- Target (mean)
- 65.38
- Target (high)
- 70.00
Ratings (0m) 8 7 buy · 1 hold · 0 sell
- Strong buy2
- Buy5
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 8
- 1 month ago 8
- 2 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.18 | 1.15 – 1.22 | 1.17 | +0.6% | 884.84M | +8.7% | 6 |
| Next quarter | 1.52 | 1.39 – 1.63 | 1.47 | +3.8% | 941.99M | +7.8% | 5 |
| Current year | 5.32 | 5.17 – 5.44 | 4.83 | +10.2% | 3.51B | +7.7% | 6 |
| Next year | 5.81 | 5.31 – 6.23 | 5.32 | +9.2% | 3.82B | +9.1% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 7, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Sep 8, 2026 | TD Cowen | Maintained | Buy | Buy |
| Aug 7, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 13, 2026 | TD Cowen | Maintained | Buy | Buy |
| May 7, 2026 | Citigroup | Maintained | Buy | Buy |
| May 7, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Apr 21, 2026 | UBS | Maintained | Buy | Buy |
| Apr 10, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jan 30, 2026 | UBS | Upgrade | Neutral | Buy |
| Jan 27, 2026 | Citigroup | Maintained | Buy | Buy |
| Dec 11, 2025 | TD Cowen | Maintained | Buy | Buy |
| Oct 10, 2025 | Morgan Stanley | Maintained | Overweight | Overweight |
| Sep 30, 2025 | Goldman Sachs | Initiated | — | Buy |
| Jul 22, 2025 | Citigroup | Maintained | Buy | Buy |
| Jul 10, 2025 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 25, 2024 | Citigroup | Maintained | Buy | Buy |
| Aug 14, 2024 | Goldman Sachs | Maintained | Buy | Buy |
| Jul 11, 2024 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jun 3, 2024 | UBS | Downgrade | Buy | Neutral |
| Apr 12, 2024 | B of A Securities | Maintained | Buy | Buy |
| Feb 20, 2024 | JP Morgan | Maintained | Overweight | Overweight |
| Feb 20, 2024 | Goldman Sachs | Maintained | Buy | Buy |
| Nov 9, 2023 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 11, 2023 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 9, 2023 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jul 11, 2023 | Morgan Stanley | Reiterated | Overweight | Overweight |
| May 10, 2023 | Morgan Stanley | Maintained | — | Overweight |
| Apr 10, 2023 | Morgan Stanley | Maintained | — | Overweight |
| Apr 6, 2023 | Tigress Financial | Reiterated | — | Buy |
| Feb 16, 2023 | UBS | Maintained | — | Buy |